Skip to content

Effect of QIGUI FUYUAN decoction on rehabilitation and recurrence prevention after stroke and its mechanism of promoting nerve regeneration

Effect of Qi-Gui Fu-Yuan decoction on rehabilitation and recurrence prevention after stroke and its mechanism of promoting nerve regeneration

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006366
Enrollment
Unknown
Registered
2022-07-19
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

TCM treatment group:Received usual care and Taking Qigui FUYUAN decoction
control group:Received usual care

Sponsors

Department of science and technology of Hainan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ? meet the above diagnostic criteria of Western medicine and TCM syndrome differentiation; ? Those aged from 18 to 80; ? The patients did not take any traditional Chinese medicine 2 weeks before enrollment; ? Normal liver and kidney function; ? Those who have not participated in other clinical drug trials recently, or have stopped taking drugs for more than half a month; ? Patients volunteered for the trial and signed informed consent.

Exclusion criteria

Exclusion criteria: ? Age 80 years old; ? Patients with severe liver, lung, heart, tumor and other diseases; ? Patients with any form of intracerebral hemorrhage; ? Simple lacunar infarction or cerebral infarction caused by posterior circulation; ? Failing to take medicine as required, unable to judge the therapeutic effect, or incomplete data affect the judgment of curative effect; ? Pregnant and lactating women; ? Those who are allergic to the drugs and have mental disorders.

Design outcomes

Primary

MeasureTime frame
NIHSS;ALT/AST;Recurrence rate of stroke;mRS;Barthel;

Secondary

MeasureTime frame
blood pressure;GLU;Incidence of Shoulder-hand Syndrome;OX-LDL;

Countries

China

Contacts

Public ContactGuoHuWeng
18689931113@163.com18689931113

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026